NEURAXIS, INC. Net Income (Loss) Available to Common Stockholders, Basic
NEURAXIS, INC. (NRXS) reported Net Income (Loss) Available to Common Stockholders, Basic of -$2.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-11
- NEURAXIS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$2.28M.
- NEURAXIS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$1.95M.
- NEURAXIS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$1.90M.
- NEURAXIS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$2.32M.
- NEURAXIS, INC. net income (loss) available to common stockholders, basic for fiscal 2025 was -$8.62M.
- NEURAXIS, INC. net income (loss) available to common stockholders, basic for fiscal 2024 was -$8.45M.
- NEURAXIS, INC. net income (loss) available to common stockholders, basic for fiscal 2023 was -$14.63M.
- NEURAXIS, INC. net income (loss) available to common stockholders, basic for fiscal 2022 was -$5.54M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.28M 10-Q · filed 2026-08-11 | -$4.23M 10-Q · filed 2026-08-11 | -$6.13M derived: sum of 3 quarters · filed 2026-08-11 | -$8.45M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | -$1.95M 10-Q · filed 2026-05-12 | -$3.85M derived: sum of 2 quarters · filed 2026-05-12 | -$6.18M derived: sum of 3 quarters · filed 2026-05-12 | -$8.07M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$4.23M derived: sum of 2 quarters · filed 2026-03-19 | -$6.12M derived: sum of 3 quarters · filed 2026-08-11 | -$8.62M 10-K · filed 2026-03-19 | ||
| 2025-09-30 | -$2.32M 10-Q · filed 2025-11-10 | -$4.22M derived: sum of 2 quarters · filed 2026-08-11 | -$6.71M 10-Q · filed 2025-11-10 | -$8.33M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | -$1.90M 10-Q · filed 2026-08-11 | -$4.39M 10-Q · filed 2026-08-11 | -$6.00M derived: sum of 3 quarters · filed 2026-08-11 | -$7.80M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | -$2.49M 10-Q · filed 2026-05-12 | -$4.11M derived: sum of 2 quarters · filed 2026-05-12 | -$5.91M derived: sum of 3 quarters · filed 2026-05-12 | -$8.82M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$3.41M derived: sum of 2 quarters · filed 2026-03-19 | -$6.33M derived: sum of 3 quarters · filed 2026-03-19 | -$8.45M 10-K · filed 2026-03-19 | ||
| 2024-09-30 | -$1.80M 10-Q · filed 2025-11-10 | -$4.72M derived: sum of 2 quarters · filed 2025-11-10 | -$6.84M 10-Q · filed 2025-11-10 | -$8.43M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | -$2.92M 10-Q · filed 2025-08-12 | -$5.04M 10-Q · filed 2025-08-12 | -$6.63M derived: sum of 3 quarters · filed 2025-08-12 | -$15.26M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$2.12M 10-Q · filed 2025-05-12 | -$3.71M derived: sum of 2 quarters · filed 2025-05-12 | -$12.34M derived: sum of 3 quarters · filed 2025-05-12 | -$14.76M derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$10.22M derived: sum of 2 quarters · filed 2025-03-20 | -$12.64M derived: sum of 3 quarters · filed 2025-03-20 | -$14.63M 10-K · filed 2025-03-20 | ||
| 2023-09-30 | -$8.63M 10-Q · filed 2024-11-12 | -$4.90M 10-Q · filed 2023-11-20 | -$11.05M derived: sum of 2 quarters · filed 2024-11-12 | -$13.03M 10-Q · filed 2024-11-12 | -$9.31M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | -$2.43M 10-Q · filed 2024-08-09 | -$4.79M 10-Q · filed 2024-08-09 | ||||
| 2022-12-31 | -$206.42K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$2.48M derived: sum of 2 quarters · filed 2024-04-16 | -$4.19M derived: sum of 3 quarters · filed 2024-04-16 | -$5.54M 10-K · filed 2024-04-16 | ||
| 2022-09-30 | -$2.27M 10-Q · filed 2023-11-20 | -$3.98M derived: sum of 2 quarters · filed 2023-11-20 | -$5.34M 10-Q · filed 2023-11-20 | |||
| 2022-06-30 | -$1.71M 10-Q · filed 2023-09-22 | -$3.07M 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |